Update in treatment of uveitic macular edema
Spyridon Koronis,1 Panagiotis Stavrakas,2 Miltiadis Balidis,1 Nikolaos Kozeis,1 Paris G Tranos1 1Ophthalmica Eye Institute, Thessaloniki, Greece; 2Department of Ophthalmology, Attikon University Hospital, Athens, Greece Abstract: Macular edema (ME) represents the most common cause for visual loss am...
Saved in:
Main Authors: | Koronis S (Author), Stavrakas P (Author), Balidis M (Author), Kozeis N (Author), Tranos PG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
by: Lucy Joanne Kessler, et al.
Published: (2022) -
Edema macular cistoideo Macular cystoid edema
by: Blanca Nieve Rey Estévez, et al.
Published: (2010) -
Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024) -
Rhegmatogenous retinal detachment due to a macular hole in a patient with pars planitis: a case report
by: Stavrakas P, et al.
Published: (2014) -
Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma
by: V. V. Savko, et al.
Published: (2018)